GSK have recently launched their Discovery Fast Track Challenge. This scheme is an opportunity for academic researchers to work with GSK scientists on the development of new medicines. It is aimed at academics that have identified a drug development concept and wish to work with GSK to translate novel science into new medicines.
The Discovery Fast Track Challenge is looking for proposals that are able to address the following questions:
Do you have a clear therapeutic hypothesis?
GSK are looking for a coherent ad supportable hypothesis for the development of a medicine that would provide therapeutic benefits to particular groups of patients.
Do you have a defined target and/or pathway?
You should have identified a specific drug target linked to disease and can propose ways of modulating this to provide a effective and safe therapy
Do you have enabling expertise?
The Discover Fast Track Challenge is a partnership. You should have generated data which provides proof of concept for your proposal and, ideally, already developed key reagents and assays.
The deadline for submission of a brief non-confidential summary is the 24th of April 2015. Please note that you should contact your relevant Technology Transfer Office in the first instance who will be able to support you with the application process.